Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Possible Pathways of Capecitabine-Induced Hand–Foot Syndrome
Yan Lou, Qian Wang, Jinqi Zheng, et al.
Chemical Research in Toxicology (2016) Vol. 29, Iss. 10, pp. 1591-1601
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Management of cytotoxic chemotherapy-induced hand-foot syndrome
Johannes J.M. Kwakman, Yannick S. Elshot, Cornelis J.A. Punt, et al.
Oncology Reviews (2020) Vol. 14, Iss. 1
Open Access | Times Cited: 109
COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study
Violaine Randrian, Amale Dhimene, Armelle Pillet, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Anti-Inflammatory Activity of Calendula officinalis L. Flower Extract
Diva Silva, Marta Ferreira, José Manuel Sousa Lobo, et al.
Cosmetics (2021) Vol. 8, Iss. 2, pp. 31-31
Open Access | Times Cited: 54
Drugs and the skin: A concise review of cutaneous adverse drug reactions
Blanca R. Del Pozzo‐Magaña, Carmen Liy‐Wong
British Journal of Clinical Pharmacology (2022) Vol. 90, Iss. 8, pp. 1838-1855
Open Access | Times Cited: 33
In vitro co-culture systems of hepatic and intestinal cells for cellular pharmacokinetic and pharmacodynamic studies of capecitabine against colorectal cancer
Chun Ge, Xintong Huang, Sujie Zhang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD
Mirjam de With, Leni van Doorn, Demi C. Maasland, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114232-114232
Open Access | Times Cited: 11
Hand-foot syndrome in cancer patients on capecitabine: examining prevalence, impacts, and associated risk factors at a cancer centre in Malaysia
Teck Long King, Pei Jye Voon, Kah Hay Yuen, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 6
Open Access | Times Cited: 4
Identification of hand-foot syndrome from cancer patients’ blog posts: BERT-based deep-learning approach to detect potential adverse drug reaction symptoms
Satoshi Nishioka, T. Watanabe, Masaki Asano, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0267901-e0267901
Open Access | Times Cited: 18
Comparative efficacy of diclofenac sodium gel and urea cream in preventing capecitabine-induced hand-foot syndrome: a randomized interventional study
Pinakin T. Tandel, C. Krishnan, Anand Praveen Kumar Anandanarayanan, et al.
International Journal of Research in Medical Sciences (2025) Vol. 13, Iss. 3, pp. 1220-1224
Open Access
Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data
Mahsa Ghodousi, Hedyieh Karbasforooshan, Leila Arabi, et al.
European Journal of Clinical Pharmacology (2022) Vol. 79, Iss. 1, pp. 15-38
Closed Access | Times Cited: 15
Incidence and severity of hand-foot syndrome in cancer patients receiving infusional 5-fluorouracil or oral capecitabine-containing chemotherapy regimens
Sulaikha Abdul Kareem, S. Joseph, A.R.M. Wilson, et al.
Journal of Oncology Pharmacy Practice (2024)
Closed Access | Times Cited: 3
Pharmacogenomics DNA Biomarkers in Colorectal Cancer: Current Update
Nurul‐Syakima Ab Mutalib, Najwa Farhah Md. Yusof, Shafina-Nadiawati Abdul, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 24
Management of colorectal cancer in the era of COVID-19: Challenges and suggestions
Walid Alam, Youssef Bouferraa, Yolla Haibe, et al.
Science Progress (2021) Vol. 104, Iss. 2
Open Access | Times Cited: 17
A preclinical evaluation of cytarabine prodrug nanofibers assembled from cytarabine-lauric acid conjugate toward solid tumors
Ruiling Liu, Yue Jiang, Hu Xu, et al.
International Journal of Pharmaceutics (2018) Vol. 552, Iss. 1-2, pp. 111-118
Closed Access | Times Cited: 19
Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome
Shiori Hiromoto, Takehiro Kawashiri, Natsumi Yamanaka, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies
Analia Rodríguez Garzotto, Lara Iglesias-Docampo, C. Vanesa Díaz-García, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 10
Risk factors for the incidence and severity of peristomal skin disorders defined using two scoring systems
Takuya Shiraishi, Yuji Nishizawa, Mifumi Nakajima, et al.
Surgery Today (2019) Vol. 50, Iss. 3, pp. 284-291
Closed Access | Times Cited: 17
Genomic methylation variations predict the susceptibility of six chemotherapy related adverse effects and cancer development for Chinese colorectal cancer patients
Mingming Li, Xiaomeng Sun, Houshan Yao, et al.
Toxicology and Applied Pharmacology (2021) Vol. 427, pp. 115657-115657
Closed Access | Times Cited: 14
Biosynthetic Silver Nanoparticles Inhibit the Malignant Behavior of Gastric Cancer Cells and Enhance the Therapeutic Effect of 5-Fluorouracil by Promoting Intracellular ROS Generation and Apoptosis
Jingwen Yuan, Shahid Ullah Khan, Jiajun Luo, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2109-2109
Open Access | Times Cited: 10
Real-World Adverse Effects of Capecitabine Toxicity in an Elderly Population
Michiel W. H. van Beek, Monique Roukens, Wilco Jacobs, et al.
Drugs - Real World Outcomes (2018) Vol. 5, Iss. 3, pp. 161-167
Open Access | Times Cited: 15
Pharmacological prevention strategy for capecitabine‐induced hand‐foot syndrome: A network meta‐analysis of randomized control trials
Yung‐Shuo Kao, Chen‐Hsu Lo, Yu‐Kang Tu, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 10
Open Access | Times Cited: 9
Capecitabine-Associated Loss of Fingerprints: Report of Capecitabine-Induced Adermatoglyphia in Two Women with Breast Cancer and Review of Acquired Dermatoglyphic Absence in Oncology Patients Treated with Capecitabine
Philip R Cohen
Cureus (2017)
Open Access | Times Cited: 13
Herbal medicine for hand–foot syndrome induced by fluoropyrimidines: A systematic review and meta‐analysis
Bo Deng, Wei Sun
Phytotherapy Research (2018) Vol. 32, Iss. 7, pp. 1211-1228
Closed Access | Times Cited: 13
P38 MAPK, NF-κB, and JAK-STAT3 Signaling Pathways Involved in Capecitabine-Induced Hand-Foot Syndrome via Interleukin 6 or Interleukin 8 Abnormal Expression
Xiaoying He, Jiali Wang, Qian Wang, et al.
Chemical Research in Toxicology (2022) Vol. 35, Iss. 3, pp. 422-430
Closed Access | Times Cited: 8
Pharmacokinetics and Comparative Bioavailability of Test or Reference Capecitabine and Discrepant Pharmacokinetics Among Various Tumors in Chinese Solid Cancer Patients
Xiaoyu Li, Dongyang Cui, Jianping Xiong, et al.
Clinical Pharmacology in Drug Development (2023) Vol. 12, Iss. 3, pp. 324-332
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top